Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings
Monica Gandhi(University of California, San Francisco), Jared M. Baeten(University of Washington), Warren C. Rodrigues, David V. Glidden(University of California, San Francisco), Paul K. Drain(University of Washington), Nelly Mugo(University of Washington), Kenneth Ngure(University of Nairobi), Hideaki Okochi, Oraphan Siriprakaisil(SanPaTong Hospital), Peter Bacchetti(University of California, San Francisco), Virat Klinbuayaem(SanPaTong Hospital), Michael S. Vincent(Pfizer (United States)), Guohong Wang(Fudan University), Tim R. Cressey, R.J.B. King(The Honourable Society of Lincoln's Inn), Matthew A. Spinelli(University of California, San Francisco)
Cited by 73
Related Papers
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
|The Lancet|2022|16k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
|Hepatology|2001|2.3k
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
Abnormal Brain Development in Newborns with Congenital Heart Disease
|New England Journal of Medicine|2007|851